ClinConnect ClinConnect Logo
Search / Trial NCT06559605

Evaluation of Bone Gain Using Customized 3D Zirconia Barrier Versus Titanium Mesh

Launched by CAIRO UNIVERSITY · Aug 14, 2024

Trial Information

Current as of September 03, 2025

Recruiting

Keywords

Zirconia Membrane Titanium Membrane Combined Bone Defect

ClinConnect Summary

This clinical trial is investigating how much bone can be gained using a specially designed 3D printed zirconia barrier compared to a traditional titanium mesh in patients with bone loss in a specific area of the jaw called the esthetic zone. The goal is to see which method is more effective in helping to rebuild the bone.

To participate in this study, individuals should be between 20 and 70 years old, have a narrow bone width of less than 4mm, and a vertical bone height of less than 9mm. They should also have healthy surrounding teeth and maintain good oral hygiene. Participants will need to commit to following post-operative care instructions and attend follow-up appointments. It is important to note that people with certain health issues, such as uncontrolled diabetes or infections in the area needing treatment, will not be eligible to join the trial. If you meet these criteria and are interested, you can expect to undergo a procedure that aims to improve your bone structure, which may ultimately benefit your dental health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: 20-70 years.
  • Bone width less than 4mm
  • Vertical bone height less than 9mm
  • Periodontally sound neighboring teeth
  • Patients with sound vertical occlusal bite dimension
  • Good oral hygiene (full mouth plaque control record \[PCR\] \< 25%,full mouth bleeding on probing (BOP) \< 25% .
  • Patients demonstrating understanding and commitment to the post-operative care regime and the study follow up timeline.
  • Good general health (including participants with well-controlled systemic disease)
  • Exclusion Criteria:
  • 1. Pathological lesions (abscess-cyst-acute infection) in the defect site
  • 2. Systemic diseases that would interfere with bone metabolism
  • 3. Uncontrolled diabetic patients
  • 4. Ongoing treatment or a history of recent chemotherapy or radiotherapy
  • 5. Poor oral hygiene after hygienic phase (Plaque control record over 30%) or Active periodontal disease

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Hani El Nahass

Study Director

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported